Over the Life Course: The Integration of Research, Health Care, and Policy & The ACA and the Future of Health Care Research in the U.S
BSSR Lecture Series "Over the Life Course: The Integration of Research, Health Care, and Policy" Neal Halfon, MD, MPH Neal Halfon, MD, MPH is director of the UCLA Center for Healthier Children, Families and Communities. He is a professor of pediatrics in the David Geffen School of Medicine at UCLA, health policy and management in the UCLA Fielding School of Public Health, and public policy in the UCLA Luskin School of Public Affairs. Dr. Halfon served as a member of the Board on Children, Youth and Families of the National Research Council and Institute of Medicine from 2001-2006, and also served on the IOM/NRC Committee on Child Health that produced the report, Children’s Health the Nation’s Wealth. Dr. Halfon has been involved with the National Children’s Study in several capacities including as a special advisor, steering committee member, director of the NCS Health Measurement Network and principal investigator for the Los Angeles County Study Center. In 2006, the Academic Pediatric Association awarded Dr. Halfon its annual Research Award in recognition of his lifetime achievement in the field of child health research. For more than a decade Dr. Halfon has been instrumental in advancing research, policy and systems innovations focused on the healthy development of children at local, national and international level. He directed the federally funded National Center for Infancy and Early Childhood Health Policy, and he currently directs the WK...
CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two areas should initially be targeted for quality improvement including development of local guidelines, documentation of antibiotic indications and/or stop/review dates. PMID: 33034234 [PubMed - as supplied by publisher]
Authors: Rombauts A, Abelenda-Alonso G, Cuervo G, Gudiol C, Carratalà J Abstract INTRODUCTION: Despite adequate antibiotic coverage, community-acquired pneumonia (CAP) remains a leading cause of hospitalization and mortality worldwide. It induces both a local pulmonary and a systemic inflammatory response, particularly significant in severe cases. The intensity of the dysregulated host response varies from patient to patient and has a negative impact on survival and other outcomes. AREAS COVERED: This comprehensive review summarizes the pathophysiological aspects of the inflammatory response in CAP, brie...
Authors: Hammerschlag MR, Sharma R Abstract INTRODUCTION: Azithromycin was recommended as the first-line therapeutic regimen for treatment of genital infections in men and women by the Centers for Disease Control in 1998. A series of studies of azithromycin for treatment of rectal chlamydial infection in men who have sex with men (MSM) found that azithromycin was significantly less effective than doxycycline. AREAS COVERED: Literature on treatment of rectal C. trachomatis from 2000 through May 2020 was searched using PubMed. Retrospective and observational studies were identified documenting the frequency and t...
Authors: Reissier S, Cattoir V Abstract INTRODUCTION: Streptogramins (pristinamycin and quinupristin-dalfopristin) can be interesting options for the treatment of infections due to Gram-positive cocci, especially multidrug-resistant isolates. AREAS COVERED: This review provides an updated overview on structural and activity characteristics, mechanisms of action and resistance, pharmacokinetic/pharmacodynamic and clinical use of streptogramins. EXPERT OPINION: The streptogramin antibiotics act by inhibition of the bacterial protein synthesis. They are composed of two chemically distinct compounds, namely typ...
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Ping He, Yi Zhang, Xinyi Zhao, Jie Wei, Tianhong Xu, Jiang Wu, Naichao Chen
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Jing Li, Haotian Li, Dongdong Lin, Muyi Li, Quansheng Wang, Song Xie, Yuming Zhang, Fengsong Liu
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part AAuthor(s): Cheng Han, Yinping Zhang, Marc Redmile-Gordon, Huan Deng, Zhenggui Gu, Qiguo Zhao, Fang Wang
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part AAuthor(s): Taesik Go, Jihwan Kim, Sang Joon Lee
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part AAuthor(s): Daeeun Kwon, Woobin Bae, Jeonghwan Kim
More News: Academia | Academies | American Health | Child Development | Children | Economics | Environmental Health | General Medicine | Genetics | Government | Harvard | Health | Health Management | Infectious Diseases | Insurance | International Medicine & Public Health | Obama | Pediatrics | Politics | Science | Study